Company / Depreciation & Amortization
vTv Therapeutics Inc. Depreciation & Amortization History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Depreciation & Amortization
$90.0K
FY2025
5-year range
$39.0K / $94.0K
FY2021-FY2025
Trend
-2.2%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Depreciation & Amortization has fluctuated over the past 10 years, ranging from $39,000 in FY2021 to $864,000 in FY2016.
Based on SEC 10-K filings.
$90,000 in FY2025 with a 5-year CAGR of -16.2%.
Remained stable around $90,000 over the past 2 years.
Depreciation & Amortization over time
Growth rates
- 3-Year CAGR
- -1.4%
- 5-Year CAGR
- -16.2%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of -16.2%, indicating a declining trend.
- In FY2025, depreciation & amortization decreased 2.2% year-over-year.
- Peak depreciation & amortization was recorded in FY2016.
- Lowest depreciation & amortization in the period was in FY2021.
Company context
Key Data Points
- Altman Z-Score 0.85 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Depreciation & AmortizationValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $90.0K | -2.2% |
| FY2024 | $92.0K | +3.4% |
| FY2023 | $89.0K | -5.3% |
| FY2022 | $94.0K | +141.0% |
| FY2021 | $39.0K | -82.1% |
| FY2020 | $218.0K | +10.7% |
| FY2019 | $197.0K | -25.7% |
| FY2018 | $265.0K | -47.1% |
| FY2017 | $501.0K | -42.0% |
| FY2016 | $864.0K | -20.4% |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026